{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:31:44Z","timestamp":1768566704184,"version":"3.49.0"},"posted":{"date-parts":[[2023,7,16]]},"group-title":"Public and Global Health","reference-count":22,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,7,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The contraceptive vaginal ring (NuvaRing), one of the Multipurpose Prevention Technologies (MPT) products, is effective in preventing unintended pregnancies and may contribute to reducing the frequency of Bacterial Vaginosis (BV), which is a risk factor for HIV acquisition, transmission, and shedding among women. NuvaRing may cause irregular menstruation, including menstrual suppression, which may influence women\u2019s decision on product choice, use, and acceptability. In this prospective cohort study, we assessed women\u2019s experiences with menstruation suppression following continued NuvaRing use.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A total of 18 in-depth interviews were conducted using a semi-structured interview guide among purposively selected women with BV in Thika, Kenya, aged 18-40 years, who used NuvaRing continuously. All women received counseling on possibility of menstrual suppression following continuous NuvaRing use. Audio recordings were transcribed verbatim and thematically analyzed.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Participants who expected and were aware that menstrual suppression was a possible side effect of Nuvaring accepted its benefits, and expressed acceptance and desire to continue using NuvaRing. Participants who had not anticipated menstrual suppression expressed anxiety and fear, with some expressing desire to continue using NuvaRing but worried about unintended negative consequences. The ability to perform daily activities uninterrupted, reduced expenses on sanitary supplies, enhanced sexual pleasure and relationships, and absence of menstrual pain were benefits of menstrual suppression. Although all participants received counseling on menstrual suppression, some expressed anxiety over the possibility of unintended pregnancy. As a result, they frequented medical facilities for health check-ups and pregnancy tests, and some used combined oral contraceptives to induce menses.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Understanding perceptions regarding menstrual suppression is crucial in offering targeted and comprehensive counseling to improve women\u2019s understanding of menstruation suppression to influence acceptance and use of NuvaRing. Additionally, improved male involvement in reproductive health concerns and women\u2019s autonomy in discussing reproductive health issues with partners is essential.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2023.07.14.23292684","type":"posted-content","created":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T13:40:11Z","timestamp":1689514811000},"source":"Crossref","is-referenced-by-count":0,"title":["Experiences and attitudes towards Menstrual Suppression among Women with Bacterial vaginosis Randomised to Continuous Use of NuvaRing in Kenya"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9568-721X","authenticated-orcid":false,"given":"Edinah","family":"Casmir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Njeri","family":"Wairimu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Kiptinness","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynda","family":"Oluoch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen Gakuo","family":"Maina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina Wilbekin","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelly","family":"Mugo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanne","family":"Marrazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Ngure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2023071905001783000_2023.07.14.23292684v1.1","unstructured":"UNAIDS data 2021 [Internet]. [cited 2022 Aug 15]. Available from: https:\/\/www.unaids.org\/en\/resources\/documents\/2021\/2021_unaids_data"},{"key":"2023071905001783000_2023.07.14.23292684v1.2","unstructured":"Global HIV & AIDS statistics \u2014 Fact sheet [Internet]. [cited 2022 Aug 15]. Available from: https:\/\/www.unaids.org\/en\/resources\/fact-sheet"},{"key":"2023071905001783000_2023.07.14.23292684v1.3","unstructured":"Kenya\u2019s National HIV Survey Shows Progress Towards Control of the Epidemic. Nairobi, 20th February 2020 \u2013 MINISTRY OF HEALTH [Internet]. [cited 2022 Aug 15]. Available from: https:\/\/www.health.go.ke\/kenyas-national-hiv-survey-shows-progress-towards-control-of-the-epidemic-nairobi-20th-february-2020\/"},{"key":"2023071905001783000_2023.07.14.23292684v1.4","unstructured":"Kenya Preliminary Report 2018 [Internet]. PHIA Project. [cited 2022 Aug 15]. Available from: https:\/\/phia.icap.columbia.edu\/kenya-preliminary-report\/"},{"key":"2023071905001783000_2023.07.14.23292684v1.5","unstructured":"WORLD AIDS DAY REPORT 2020.pdf | Powered by Box [Internet]. [cited 2022 Aug 15]. Available from: https:\/\/app.box.com\/s\/kb1f0tkbjhlcn2a610too8vlpizxqla8"},{"issue":"3","key":"2023071905001783000_2023.07.14.23292684v1.6","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s10461-021-03434-2","article-title":"Integration of a Relationship-focused Counseling Intervention with Delivery of the Dapivirine Ring for HIV Prevention to Women in Johannesburg: Results of the CHARISMA Pilot Study","volume":"26","year":"2022","journal-title":"AIDS Behav"},{"issue":"6","key":"2023071905001783000_2023.07.14.23292684v1.7","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1007\/s10461-020-03119-2","article-title":"Men\u2019s Sexual Experiences with the Dapivirine Vaginal Ring in Malawi, South Africa, Uganda and Zimbabwe","volume":"25","year":"2021","journal-title":"AIDS Behav"},{"issue":"5","key":"2023071905001783000_2023.07.14.23292684v1.8","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1007\/s10461-019-02707-1","article-title":"Impact of Male Partner Involvement on Women\u2019s Adherence to the Dapivirine Vaginal Ring During a Phase III HIV Prevention Trial","volume":"24","year":"2020","journal-title":"AIDS Behav"},{"issue":"3","key":"2023071905001783000_2023.07.14.23292684v1.9","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s10461-019-02521-9","article-title":"Relationship Type and Use of the Vaginal Ring for HIV-1 Prevention in the MTN 020\/ASPIRE Trial","volume":"24","year":"2020","journal-title":"AIDS Behav"},{"key":"2023071905001783000_2023.07.14.23292684v1.10","doi-asserted-by":"crossref","unstructured":"Young Holt B , Turpin JA , Romano J. Multipurpose Prevention Technologies: Opportunities and Challenges to Ensure Advancement of the Most Promising MPTs. Frontiers in Reproductive Health [Internet]. 2021 [cited 2022 Aug 15];3. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/frph.2021.704841","DOI":"10.3389\/frph.2021.704841"},{"issue":"6","key":"2023071905001783000_2023.07.14.23292684v1.11","doi-asserted-by":"crossref","first-page":"e1001251","DOI":"10.1371\/journal.pmed.1001251","article-title":"Bacterial Vaginosis Associated with Increased Risk of Female-to-Male HIV-1 Transmission: A Prospective Cohort Analysis among African Couples","volume":"9","year":"2012","journal-title":"PLOS Medicine"},{"issue":"2","key":"2023071905001783000_2023.07.14.23292684v1.12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ajog.2018.10.014","article-title":"Diversity of vaginal microbiota in sub-Saharan Africa and its effects on HIV transmission and prevention","volume":"220","year":"2019","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"2023071905001783000_2023.07.14.23292684v1.13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12978-018-0561-0","article-title":"There might be blood: a scoping review on women\u2019s responses to contraceptive-induced menstrual bleeding changes","volume":"15","year":"2018","journal-title":"Reproductive Health"},{"issue":"1","key":"2023071905001783000_2023.07.14.23292684v1.14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/03630242.2019.1607803","article-title":"\u201cThe state of mind tells me it\u2019s dirty\u201d: menstrual shame amongst women using a vaginal ring in Sub Saharan Africa","volume":"60","year":"2020","journal-title":"Women Health"},{"issue":"2","key":"2023071905001783000_2023.07.14.23292684v1.15","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10461-019-02514-8","article-title":"Hygiene, Blood Flow, and Vaginal Overload: Why Women Removed an HIV Prevention Vaginal Ring During Menstruation in Malawi, South Africa, Uganda and Zimbabwe","volume":"24","year":"2020","journal-title":"AIDS Behav"},{"issue":"3","key":"2023071905001783000_2023.07.14.23292684v1.16","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4274\/jtgga.galenos.2018.2018.0122","article-title":". The effect of gender-role orientation on attitudes towards menstruation in a sample of female university students","volume":"20","year":"2019","journal-title":"J Turk Ger Gynecol Assoc"},{"issue":"6","key":"2023071905001783000_2023.07.14.23292684v1.17","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.contraception.2009.12.010","article-title":"Role of menstruation in contraceptive choice among HIV-infected women in Soweto, South Africa","volume":"81","year":"2010","journal-title":"Contraception"},{"key":"2023071905001783000_2023.07.14.23292684v1.18","doi-asserted-by":"publisher","DOI":"10.15761\/FWH.1000122"},{"key":"2023071905001783000_2023.07.14.23292684v1.19","first-page":"631","article-title":"Menstrual suppression: current perspectives","volume":"6","year":"2014","journal-title":"Int J Womens Health"},{"issue":"4","key":"2023071905001783000_2023.07.14.23292684v1.20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.whi.2010.03.002","article-title":"Military Women\u2019s Attitudes Toward Menstruation and Menstrual Suppression in Relation to the Deployed Environment: Development and Testing of the MWATMS-9 (Short Form)","volume":"20","year":"2010","journal-title":"Women\u2019s Health Issues"},{"issue":"2","key":"2023071905001783000_2023.07.14.23292684v1.21","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s10461-010-9848-z","article-title":"Influence of culture on contraceptive utilization among HIV-positive women in Brazil, Kenya, and South Africa","volume":"15","year":"2011","journal-title":"AIDS Behav"},{"issue":"1","key":"2023071905001783000_2023.07.14.23292684v1.22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12905-021-01321-5","article-title":"Experiences with simultaneous use of contraception and the vaginal ring for HIV prevention in sub-Saharan Africa","volume":"21","year":"2021","journal-title":"BMC Women\u2019s Health"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2023.07.14.23292684","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T19:37:11Z","timestamp":1768505831000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2023.07.14.23292684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,16]]},"references-count":22,"URL":"https:\/\/doi.org\/10.1101\/2023.07.14.23292684","relation":{},"subject":[],"published":{"date-parts":[[2023,7,16]]},"subtype":"preprint"}}